Dual-function AAV gene therapy reverses late-stage Canavan disease pathology in mice

The leukodystrophy Canavan disease is a fatal white matter disorder caused by loss-of-function mutations of the aspartoacylase-encoding ASPA gene. There are no effective treatments available and experimental gene therapy trials have failed to provide sufficient amelioration from Canavan disease symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Fröhlich, Dominik, Kalotay, Elizabeth, von Jonquieres, Georg, Bongers, Andre, Lee, Brendan, Suchowerska, Alexandra K., Housley, Gary D., Klugmann, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772617/
https://www.ncbi.nlm.nih.gov/pubmed/36568275
http://dx.doi.org/10.3389/fnmol.2022.1061257

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772617/
https://www.ncbi.nlm.nih.gov/pubmed/36568275
http://dx.doi.org/10.3389/fnmol.2022.1061257

Ejemplares similares